Growth Metrics

Omnicell (OMCL) Liabilities and Shareholders Equity (2016 - 2026)

Omnicell has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $2.0 billion for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 6.89% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.2 billion through Dec 2025, down 8.66% year-over-year, with the annual reading at $2.0 billion for FY2025, 6.89% down from the prior year.
  • Liabilities and Shareholders Equity was $2.0 billion for Q4 2025 at Omnicell, up from $1.9 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $2.3 billion in Q3 2024 and troughed at $1.9 billion in Q1 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $2.1 billion (2025), against an average of $2.1 billion.
  • Year-over-year, Liabilities and Shareholders Equity surged 60.42% in 2021 and then decreased 15.41% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.1 billion in 2021, then rose by 3.19% to $2.2 billion in 2022, then rose by 0.73% to $2.2 billion in 2023, then decreased by 4.76% to $2.1 billion in 2024, then fell by 6.89% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for OMCL's Liabilities and Shareholders Equity are $2.0 billion (Q4 2025), $1.9 billion (Q3 2025), and $2.1 billion (Q2 2025).